HSBC HOLDINGS PLC

Position in EDIT — Editas Medicine, Inc.

CIK 873630 LONDON, X0

Position in EDIT

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$277,099

+$47,118 QoQ

Shares Held

112,186

0.0% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. EDIT ranks #76 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$277,099	112,186	0.0%	Shares	Defined	2026-04-30
2025-12-31	$229,981	112,186	+17.0%	Shares	Defined	2026-03-20
2025-09-30	$332,766	95,898	+80.8%	Shares	Defined	2025-11-13
2025-06-30	$116,661	53,028	-9.1%	Shares	Defined	2025-08-13
2025-03-31	$67,643	58,313	-0.1%	Shares	Defined	2025-05-14
2024-12-31	$74,137	58,376	+3.0%	Shares	Defined	2025-02-14
2024-09-30	$193,179	56,651	-45.9%	Shares	Defined	2024-11-14
2024-06-30	$489,387	104,794	+148.1%	Shares	Defined	2024-08-12
2024-03-31	$313,368	42,233	+33.9%	Shares	Defined	2024-05-15
2023-12-31	$319,469	31,537	+1.0%	Shares	Defined	2024-02-12
2023-09-30	$243,632	31,235	+147.2%	Shares	Defined	2023-11-13
2023-06-30	$103,969	12,633	-11.6%	Shares	Defined	2023-08-11
2023-03-31	$103,624	14,293	+8.5%	Shares	Defined	2023-05-15
2020-09-30	$369,774	13,178	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.